Job Opening at Biogen
Explore Opportunities here We want your opinion !
In order to further improve the quality of the meeting, we kindly ask you to take part in a short on-line survey Follow us!
Spread the word with #NovAliXConference
|
Confirmed Exhibitors
Biosensing Instrument
Biosensing Instrument’s new SPRm 200 is the world’s first commercial SPR Microscopy, which integrates optical imaging and SPR technology. Designed especially for in-vitro, label-free measurement of binding activity and cell binding kinetics, SPRm 200 provides a spatial visualization of cellular structures together with local binding of cell membrane proteins.
|
Bruker BioSpin
One of the world's leading analytical instrumentation companies, Bruker provides the best technological solutions for each analytical task. Bruker systems cover a broad spectrum of applications in all fields of research and development and are used in all industrial production processes for the purpose of ensuring quality and process reliability.
|
ChemPartner
ChemPartner is a leading research organization providing high-quality and cost-effective services for the biopharmaceutical industry. We offer
a broad range of integrated services across the drug discovery and development process to pharmaceutical and biotechnology companies
around the globe.
|
Creoptix AG
Creoptix revolutionizes the study of molecular interactions: The combination of unparalleled sensitivity, crude sample robustness and a broad kinetic range now allow membrane protein studies in crude membranes, antibody-kinetics in pure serum or accurate kinetic characterization of weak binders. Join us to ride the wave of the future in kinetics!
|
GE Healthcare
The Life Sciences business of GE Healthcare provides expertise and tools for a wide range of applications, including basic research of cells and proteins, drug discovery and technologies to support large-scale manufacturing of vaccines and biopharmaceuticals, the fastest-growing class of medicines that target some of the toughest diseases facing the world, from diabetes to cancer to autoimmune diseases.
|
NMX Research and Solutions Inc
NMX conducts drug discovery programs via contract research organization and strategic partnership business models. Our ambition is to become a leader not only in the use of NMR spectroscopy tools but also in employing molecular biology, biophysic and synthetic chemistry strategies for identification of the seeds for tomorrow’s innovative drugs.
|
NovAliX
NovAliX is a drug discovery-focused CRO with several unique technologies.
It is highly proficient in chemistry and biophysics. The company has set up
one of the world’s most comprehensive biophysics platforms. Our commitment
and reliability are much appreciated by a worldwide client base.
|
Pall ForteBio LLC
Pall ForteBio market leader of robust, label-free molecular interaction analysis across academic research, drug discovery and development, process analytics, and manufacturing.
|
Sierra Sensors
Sierra Sensors, a global supplier of real-time, label-free molecular interaction analysis systems. Combining proprietary microfluidics, high-sensitivity SPR biosensor detection and flexible surface chemistry, we provide high-performance instruments for research and analytical laboratories. Our systems are ideal for the biophysical characterization of proteins, antibodies, DNA/RNA, small molecules, fragments, membranes and cells.
|
Thermo Fisher Scientific
Thermo Fisher Scientific, the world leader in serving science, provides complete workflows, from cryo-EM structural determination of macromolecular complexes in native state to 3D reconstruction of tissues and cells. Our solutions help unlock mysteries of underlying protein function and cellular process, bridging the gap between basic science and translational therapeutics.
|
WuXi AppTec
WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform company, providing a broad and integrated portfolio of services to help our customers and partners shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient solutions.
|
|
|
|